Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Use of the OMERACT Ultrasound Tenosynovitis Scoring System in Multicenter Clinical Trials

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Susan J Bartlett
  • Skye P Barbic
  • Vivian P Bykerk
  • Ernest H Choy
  • Rieke Alten
  • Robin Christensen
  • Alfons den Broeder
  • Bruno Fautrel
  • Daniel E Furst
  • Francis Guillemin
  • Sarah Hewlett
  • Amye L Leong
  • Anne Lyddiatt
  • Lyn March
  • Pamela Montie
  • Christoph Pohl
  • Marieke Scholte Voshaar
  • Thasia G Woodworth
  • Clifton O Bingham
Vis graf over relationer

OBJECTIVE: The Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis (RA) Flare Group was established to develop a reliable way to identify and measure RA flares in randomized controlled trials (RCT). Here, we summarized the development and field testing of the RA Flare Questionnaire (RA-FQ), and the voting results at OMERACT 2016.

METHODS: Classic and modern psychometric methods were used to assess reliability, validity, sensitivity, factor structure, scoring, and thresholds. Interviews with patients and clinicians also assessed content validity, utility, and meaningfulness of RA-FQ scores.

RESULTS: People with RA in observational trials in Canada (n = 896) and France (n = 138), and an RCT in the Netherlands (n = 178) completed 5 items (11-point numerical rating scale) representing RA Flare core domains. There was moderate to high evidence of reliability, content and construct validity, and responsiveness. Factor analysis supported unidimensionality. Rasch analysis showed acceptable fit to the Rasch model, with items and people covering a broad measurement continuum and evidence of appropriate targeting of items to people, ordered thresholds, minimal differential item functioning by language, sex, or age. A summative score across items is defensible, yielding an interval score (0-50) where higher scores reflect worsening flare. The RA-FQ received endorsement from 88% of attendees that it passed the OMERACT Filter 2.0 "Eyeball Test" for instrument selection.

CONCLUSION: The RA-FQ has been developed to identify and measure RA flares. Its review through OMERACT Filter 2.0 shows evidence of reliability, content and construct validity, and responsiveness. These properties merit its further validation as an outcome for clinical trials.

OriginalsprogEngelsk
TidsskriftJournal of Rheumatology
Vol/bind44
Udgave nummer10
Sider (fra-til)1536-1543
Antal sider8
ISSN0315-162X
DOI
StatusUdgivet - okt. 2017

ID: 52010187